Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 60

Adapalene gel versus cryotherapy for recurrent plantar warts

Official title: Comparison of Efficacy of Topical Adapalene Gel Versus Cryotherapy in Recurrent Plantar Warts

Run by Khyber Teaching Hospital · NCT07016360 · Data updated 2026-11-12

This will try topical adapalene 0.1% gel versus cryotherapy (liquid nitrogen) in adults aged 18–60 with recurrent plantar warts.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment98 (estimated)
SponsorKhyber Teaching Hospital
Academic / other
Locations1 site (Peshawar, Khyber Pakhtunkhwa)
StatusRecruiting
StartedSeptember 15, 2025
Main results expectedFebruary 15, 2026
Study endsSeptember 15, 2026
Registry record updatedApril 29, 2026
Trial IDNCT07016360 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–60 with recurrent plantar warts who are not pregnant or breastfeeding, not taking immunosuppressants, not recently treated topically or systemically for warts, without local secondary infection, and with five or fewer lesions are ideal candidates.

Probably not a fit

Patients who are pregnant or breastfeeding, on immunosuppressants, recently treated for warts, have local secondary infection, or have more than five lesions are unlikely to be eligible or to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 4 interventional comparison enrolls adults with recurrent plantar warts at Khyber Teaching Hospital to receive either topical adapalene 0.1% gel or periodic cryotherapy with liquid nitrogen. Participants will be treated and followed at scheduled visits to document wart clearance, recurrence, and any side effects. Eligible adults are 18–60 years old, not pregnant or lactating, not on recent topical or systemic wart therapies or immunosuppressants, and without local secondary infection or more than five lesions. The study compares clinical efficacy and tolerability of the topical retinoid versus cryotherapy to help guide routine care for recurrent plantar warts.

Why it matters

Potential benefit: If successful, the topical adapalene could provide an effective, potentially less painful and more convenient alternative to cryotherapy for recurrent plantar warts.

How similar studies have gone: Cryotherapy is an established standard treatment with known efficacy, while topical retinoids such as adapalene have shown mixed but sometimes promising results in smaller studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\-

Patients age limit 18-60 Years Patients with either gender (Male/Female) Patients with recurrent plantar warts

Exclusion Criteria:

* Pregnancy/lactation. Pt on topical or systemic therapy in last 6 months. On immunosuppressants. \> 5 lesions. Pts with local secondary infections.

Where it's running

  • Khyber Teaching Hospital
    Peshawar, Khyber Pakhtunkhwa, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.